Updates in Locally Advanced Pancreatic Cancer
نویسندگان
چکیده
Author Title Number of patients Study type #4060 Heinemann et al. [1] Randomized phase II trial with an uPA inhibitor (WX-671) in patients with locally advanced nonmetastatic pancreatic cancer 95 Prospective Randomized; phase II #4058 Ioka et al. [7] A multicenter phase II trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer 61 Prospective Single arm; phase II
منابع مشابه
Role of neoadjuvant therapy in management of pancreatic cancer.
Surgery remains the only curative treatment for pancreatic cancer; however, majority of patients present with advanced unresectable disease upon diagnosis. Treatment of nonmetastatic, locally advanced pancreatic cancer (LAPC) continues to require multidisciplinary bimodality or trimodality approach. Neoadjuvant therapies have been investigated for LAPC given its established role in other solid ...
متن کاملIs there an optimal neoadjuvant therapy for locally advanced pancreatic cancer?
Treatment of locally advanced pancreatic cancer is challenging. Despite continuing research, effective treatments continue to be elusive with median survival of only 8-12 months. Treatment options for locally advanced pancreatic cancer include radiation therapy, concurrent chemoradiation or chemotherapy. It is felt that radiation therapy is a suboptimal treatment as most of patients will die of...
متن کاملUpdates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Gemcitabine monotherapy and gemcitabine-based regimens are the current standard of care for locally advanced or metastatic pancreatic adenocarcinoma. However, there is still great controversy over the role of salvage chemotherapy after failure of gemcitabine. This review is an update on the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting regarding the most important development...
متن کاملCase report: Irreversible electroporation for locally advanced pancreatic cancer
INTRODUCTION For patients with pancreatic adenocarcinoma who are not candidates for surgical resection, long-term survival is poor, even with currently available systemic and radiation therapy options. However, for those with locally advanced disease who do not have distant metastasis, locoregional control of the tumor has the potential to improve long-term outcomes. A newly developed technolog...
متن کاملPositive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer.
BACKGROUND Peritoneal lavage cytology in the staging of pancreatic cancer is not widely used given improvements in computed tomography (CT). The aim of this study was to determine the utility of peritoneal lavage cytology in predicting survival in locally advanced pancreatic cancer. METHODS Between 2000 and 2008, 202 patients with biopsy-proven pancreatic cancer who were determined by pancrea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2010